Frazier Healthcare Partners LLC is facing claims that it repeatedly made bogus noises about acquiring a pharmacy technology company as part of a scheme to build a $1.5 billion business by poaching employees and stealing trade secrets.
The lawsuit targets various Frazier affiliates, as well as Parata Inc., which the private equity firm allegedly sold to medical device giant
Frazier “acquired this information under false pretenses while feigning interest” in ARxIUM’s central fill unit, OptiFill, according to the complaint filed ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.